These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12435777)

  • 1. Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy.
    Heath KV; Chan KJ; Singer J; O'Shaughnessy MV; Montaner JS; Hogg RS
    Int J Epidemiol; 2002 Oct; 31(5):1016-20. PubMed ID: 12435777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort.
    Heath KV; Hogg RS; Singer J; Chan KJ; O'Shaughnessy MV; Montaner JS
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):440-7. PubMed ID: 12138351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.
    Heath KV; Hogg RS; Chan KJ; Harris M; Montessori V; O'Shaughnessy MV; Montanera JS
    AIDS; 2001 Jan; 15(2):231-9. PubMed ID: 11216932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors.
    Santiprabhob J; Chokephaibulkit K; Khantee P; Maleesatharn A; Phonrat B; Phongsamart W; Lapphra K; Wittawatmongkol O; Rungmaitree S; Tanchaweng S; Maturapat S; Lermankul W; Tungtrongchitr R
    Cytokine; 2020 Dec; 136():155145. PubMed ID: 32920318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.
    Rakotoambinina B; Médioni J; Rabian C; Jubault V; Jais JP; Viard JP
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):443-9. PubMed ID: 11511820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
    Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
    HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
    Martinez E; Mocroft A; García-Viejo MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Bianchi L; Conget I; Blanch J; Phillips A; Gatell JM
    Lancet; 2001 Feb; 357(9256):592-8. PubMed ID: 11558485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.
    Tsiodras S; Mantzoros C; Hammer S; Samore M
    Arch Intern Med; 2000 Jul; 160(13):2050-6. PubMed ID: 10888979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipodystrophy in children and adolescents with acquired immunodeficiency syndrome and its relationship with the antiretroviral therapy employed.
    Sarni RO; Souza FI; Battistini TR; Pitta TS; Fernandes AP; Tardini PC; Fonseca FL; Dos Santos VP; Lopez FA
    J Pediatr (Rio J); 2009; 85(4):329-34. PubMed ID: 19668909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.
    Bhutia E; Hemal A; Yadav TP; Ramesh KL
    Afr Health Sci; 2014 Jun; 14(2):408-13. PubMed ID: 25320591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
    van Griensven J; De Naeyer L; Mushi T; Ubarijoro S; Gashumba D; Gazille C; Zachariah R
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.
    Piloya T; Bakeera-Kitaka S; Kekitiinwa A; Kamya MR
    J Int AIDS Soc; 2012 Jul; 15(2):17427. PubMed ID: 22814353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study.
    Galli M; Cozzi-Lepri A; Ridolfo AL; Gervasoni C; Ravasio L; Corsico L; Gianelli E; Vaccarezza M; Vullo V; Cargnel A; Minoli L; Coronado O; Giacometti A; Antinori A; Antonucci G; D'Arminio Monforte A; Moroni M;
    Arch Intern Med; 2002 Dec 9-23; 162(22):2621-8. PubMed ID: 12456235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
    Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthropometric definitions for antiretroviral-associated lipodystrophy derived from a longitudinal South African cohort with serial dual-energy X-ray absorptiometry measurements.
    Abrahams Z; Maartens G; Levitt N; Dave J
    Int J STD AIDS; 2018 Oct; 29(12):1194-1203. PubMed ID: 29945538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.
    Hartman K; Verweel G; de Groot R; Hartwig NG
    Pediatr Infect Dis J; 2006 May; 25(5):427-31. PubMed ID: 16645507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy.
    Kratz M; Purnell JQ; Breen PA; Thomas KK; Utzschneider KM; Carr DB; Kahn SE; Hughes JP; Rutledge EA; Van Yserloo B; Yukawa M; Weigle DS
    J Clin Endocrinol Metab; 2008 Mar; 93(3):959-66. PubMed ID: 18089690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.